Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Alternext  >  Neovacs    ALNEV   FR0004032746

NEOVACS (ALNEV)

Delayed Quote. Delayed  - 05/06 05:36:29 pm
1.13 EUR   -2.59%
04/29 NEOVACS : obtains FDA approval to extend its Phase IIb clinical tria..
04/28 NEOVACS : obtains FDA approval to extend its Phase IIb clinical tria..
03/21 NEOVACS : Will attend the 2016 european smallcap event
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Alternext
05/02/2016 05/03/2016 05/04/2016 05/05/2016 05/06/2016 Date
1.21(c) 1.2(c) 1.16(c) 1.16(c) 1.13 Last
314 777 400 688 228 381 98 829 114 662 Volume
-2.42% -0.83% -3.33% 0.00% -2.59% Change
More quotes
Financials (€)
Sales 2016 0,20 M
EBIT 2016 -10,5 M
Net income 2016 -7,90 M
Debt 2016 -
Yield 2016 -
Sales 2017 0,20 M
EBIT 2017 -12,5 M
Net income 2017 -9,90 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales 2016 186x
Capi. / Sales 2017 186x
Capitalization 37,2 M
More Financials
Company
Neovacs SA is a biotechnology company which engages in the development of active immunotherapies for treating auto-immune, inflammatory, and cancerous diseases.It focuses on the development of Tumor Necrosis Factor-Kinoid for treating Crohn's disease and rheumatoid polyarthritis, and... 
More about the company
Latest news on NEOVACS
04/29 NEOVACS : obtains FDA approval to extend its Phase IIb clinical trial in Lupus t..
04/28 NEOVACS : obtains FDA approval to extend its Phase IIb clinical trial in Lupus t..
04/28 DGAP-NEWS : Neovacs obtains FDA approval to extend its Phase IIb clinical trial ..
04/14 NEOVACS : OBTAINS SOUTH KOREA HEALTH AUTHORITY APPROVAL FOR IND APPLICATION WITH..
03/21 NEOVACS : Will attend the 2016 european smallcap event
03/07 NEOVACS : Reports full year 2015 financial results
03/07 NEOVACS : REPORTS FULL YEAR 2015 FINANCIAL RESULTS (DGAP News)
02/10 NEOVACS : will be at BIO Trinity 2016
More news
Sector news : Biotechnology & Medical Research - NEC
05/06 AMGEN : To Present At The Bank Of America Merrill Lynch 2016 Health Care Confere..
05/06 Cell Source Improving Immunotherapy with T-Cell Twist
05/06DJSanofi Pressures Biotech Company On Bid -- WSJ
More sector news : Biotechnology & Medical Research - NEC


Comments 
Advertisement
Chart NEOVACS
Duration : Period :
Neovacs Technical Analysis Chart | ALNEV | FR0004032746 | 4-Traders
Full-screen chart
Technical analysis trends NEOVACS
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials